Exact Mass: 495.09878260000005
Exact Mass Matches: 495.09878260000005
Found 106 metabolites which its exact mass value is equals to given mass value 495.09878260000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Isopentenyl-ADP
C15H23N5O10P2 (495.09201179999997)
A purine ribonucleoside 5-diphosphate that is ADP substituted at position N-6 by a dimethylallyl (isopentenyl) group.
Sodium folinate
C20H22N7NaO7 (495.14783420000003)
V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AF - Detoxifying agents for antineoplastic treatment
3-Azetidinecarboxamide, 1-(7-(2-chlorophenyl)-8-(4-chlorophenyl)-2-methylpyrazolo(1,5-a)-1,3,5-triazin-4-yl)-3-(ethylamino)-
High Temperature Requirement A2 Inhibitor I
C27H17N3O5S (495.08888720000004)
1,3,6-O-trinicotinoyl-alpha-D-glucopyranose
C24H21N3O9 (495.12777360000007)
N-(2-beta-D-glucopyranosyl-5-hydroxysalicyl)-5-hydroxy-6-methoxyanthranilic acid methyl ester
Cys Asp Met Gln
Cys Asp Gln Met
Cys Glu Met Asn
Cys Glu Asn Met
Cys Met Asp Gln
Cys Met Glu Asn
Cys Met Asn Glu
Cys Met Gln Asp
Cys Asn Glu Met
Cys Asn Met Glu
Cys Gln Asp Met
Cys Gln Met Asp
Asp Cys Met Gln
Asp Cys Gln Met
Asp Met Cys Gln
Asp Met Gln Cys
Asp Gln Cys Met
Asp Gln Met Cys
Glu Cys Met Asn
Glu Cys Asn Met
Glu Met Cys Asn
Glu Met Asn Cys
Glu Asn Cys Met
Glu Asn Met Cys
Met Cys Asp Gln
Met Cys Glu Asn
Met Cys Asn Glu
Met Cys Gln Asp
Met Asp Cys Gln
Met Asp Gln Cys
Met Glu Cys Asn
Met Glu Asn Cys
Met Asn Cys Glu
Met Asn Glu Cys
Met Gln Cys Asp
Met Gln Asp Cys
Asn Cys Glu Met
Asn Cys Met Glu
Asn Glu Cys Met
Asn Glu Met Cys
Asn Met Cys Glu
Asn Met Glu Cys
Gln Cys Asp Met
Gln Cys Met Asp
Gln Asp Cys Met
Gln Asp Met Cys
Gln Met Cys Asp
Gln Met Asp Cys
1,2-dihydro-6-hydroxy-3,4-dimethyl-2-oxo-5-[[4-(phenylazo)phenyl]azo]-1,3-bipyridinium chloride
C24H21Cl2N6O2 (495.11029659999997)
4-((4-(DIETHYLAMINO)-2-HYDROXYPHENYL)DIAZENYL)-5-HYDROXYNAPHTHALENE-2,7-DISULFONIC ACID
4-[(2,5-dichlorophenyl)azo]-N-(2,5-dimethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide
C25H19Cl2N3O4 (495.07525540000006)
(Z)-3-(((4-((dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-6-iodoindolin-2-one
(R)-4-tert-Butyl-2-[(R)-2-(bis(1-phenyl)-phosphino)ferrocen-1-yl]oxazoline
(N-methyl-n-phenylamino)triphenylphosphonium iodide
High Temperature Requirement A2 Inhibitor I
C27H17N3O5S (495.08888720000004)
N-(3-methoxyphenyl)-2-{(2Z)-4-oxo-3-phenyl-2-[(phenylsulfonyl)imino]-1,3-thiazolidin-5-yl}acetamide
C24H21N3O5S2 (495.09225760000004)
(2S)-2-[(2,4-Dichloro-benzoyl)-(3-trifluoromethyl-benzyl)-amino]-3-phenyl-propionic acid
C24H18Cl2F3NO3 (495.06157740000003)
N(6)-(Dimethylallyl)adenosine 5-diphosphate
C15H23N5O10P2 (495.09201179999997)
2-amino-3-hydroxy-4-methylbenzoyl-AMP(1-)
C18H20N6O9P- (495.10293400000006)
An organophosphate oxoanion obtained by deprotonation of the phosphate OH group of 2-amino-3-hydroxy-4-methylbenzoyl-AMP; the major species at pH 7.3.
[(5E)-5-sulfooxyimino-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylpentyl] benzoate
C18H25NO11S2 (495.08689799999996)
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(1H-indol-3-ylmethylcarbamothioylsulfanyl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(6-chloro-2-phenylpyrimidin-4-yl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
C20H22ClN5O6S (495.0979262000001)
2-[[3-(3,4-dichlorophenyl)-4-oxo-2-quinazolinyl]thio]-N-(2,3-dihydro-1H-inden-5-yl)acetamide
C25H19Cl2N3O2S (495.05749740000005)
2-chloro-N-(2,3-dihydro-1H-inden-5-yl)-5-[(4-phenyl-1-piperazinyl)sulfonyl]benzamide
C26H26ClN3O3S (495.13833160000013)
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
methyl (1S,9R,10R,11R)-10-(hydroxymethyl)-12-(2-methylphenyl)sulfonyl-6-oxo-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
C25H25N3O6S (495.14639900000003)
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
methyl (1R,9S,10S,11S)-10-(hydroxymethyl)-12-(2-methylphenyl)sulfonyl-6-oxo-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
C25H25N3O6S (495.14639900000003)
3-[4-[(1S,5R)-3-(3-chlorophenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
C26H26ClN3O3S (495.13833160000013)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
(6R,7R)-7-[3-(difluoromethylsulfanyl)-2-oxopropyl]-3-[[1-(2-hydroxyethyl)tetrazol-5-yl]sulfanylmethyl]-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
N(6)-(Dimethylallyl)adenosine 5'-diphosphate
C15H23N5O10P2 (495.09201179999997)
IPI-9119
IPI-9119 is an orally active, selective and irreversible FASN inhibitor with an IC50 of 0.3 nM in vitro biochemical assay. IPI-9119 inhibits tumor growth of castration-resistant prostate cancer (CRPC) xenografts mouse models[1][2].
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(6-hydroxy-4,7-diphenyl-1,3-benzothiazol-5-yl)oxy]oxane-2-carboxylic acid
C25H21NO8S (495.09878260000005)
2,5-dimethyl 3,4-bis(5-chloro-1h-indol-3-yl)-1-methylpyrrole-2,5-dicarboxylate
C25H19Cl2N3O4 (495.07525540000006)